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maintenance therapy for CMV retinitis and the pre- 
liminary results are promising, with similar efficacy to 
that of standard regimens of intravenous ganciclovir 
delivered 5 or 7 daydweek. As the number of AIDS 
patients with CMV retinitis is increasing, more patients 
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Figure 1 Survival and control of CMV retinitis in 33 study 
patients receiving thrice-weekly maintenance ganciclovir or 
foscarnet therapy: (A) Time without retinitis progression (17 
patients progressed, 16 censored; median 18 weeks); (B) Time of 
survival free of retinitis (25 patients died or relapsed, 8 censored; 
median 14 weeks); (C) Time of survival from diagnosis of retinitis 
(22 patients died, 11 censored median 34 weeks). 
will need maintenance therapy. A thrice-weekly 
approach is clearly more comfortable for the patients 
and less time-consuming. Our study indicates that this 
hypothesis should be further tested in a prospective 
randomized trial. 
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Infection caused by Ochrobactrum anthropi 
To the Editors: 
Ochrobactvum anthropi (formerly Centers for Disease 
Control group Vd), Alcaligenes xylosoxidans subspecies 
xylosoxidans, and Agrobacterium radiobacter belong to 
the former genus Achromobacter [l]. These pathogens 
are glucose-non-fermentative, non-fastidious, oxidase- 
positive, motile (by peritrichous flagella) gram-negative 
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bacilli [I], and have been isolated froni environniental 
and hospital water sources 121. Three types of infections 
in humans are known to be caused by 0. anthroyi: 
Sporadic or community-acquired infections [3];  
bacteremia of endogenous or environmental origin 
[I ,441; and outbreaks of nosocomial bactereniia associ- 
ated with contamination of sterile fluids [2]. This 
report describes two new cases of 0. anthropi infection 
in iinniunoconiproniised patients. 
Case one: A 26-year-old woman, with granulo- 
cytic sarcoma of the lung (diagnosed 2 months 
previously by endotracheal biopsy) in remission after 
chemotherapy, was subjected to excision of the right 
upper lobe of the lung, which showed opacity on 
radiography. Histology of the operative specimen 
showed infiltration by inflammatory, but not neoplastic, 
cells. The lung lesion yelded a scanty pure culture 
of 0. anthropi (identified by API 20 NE System, 
bioMkrieux, Marcy l'Etoile, France). Eight days after 
thoracotoniy, the patient developed fever, cough and 
right pleuritic pain. 
A Hickman catheter had been in place for 6 
months through which four blood speciniens were 
obtained from the peripheral vein. All blood cultures 
grew Ruvkholdevia cepacia and 0. atithropi. The latter 
was susceptible to aminoglycosides, inlipenem, cipro- 
floxacin and trimethoprim-sulfaniethoxazole, and 
resistant to ampicilin, amoxicillin-clavulanic acid, 
cefotaxinie and ceftazidime, as determined by a disk- 
diffusion method. Culture of the pleural effusion was 
sterile. 
The patient was successfully treated with oral 
ciprofloxacin for 10 days and, with the catheter still in 
place, subsequent blood cultures remained sterile. 
Case two: A 62-year-old woman with plasma cell 
niyelonia was admitted because of fever. Blood 
specimens taken on admission via a Hickman catheter 
that had been in place for 9 months yielded Escherichin 
coli, Enterobacter cloacae and viridans streptococci. 
Ceftazidinie was administered through the catheter. 
O n  day 7, the patient developed shaking chills, hypo- 
tension, tachycardia and a high fever (39.8"C) 
associated with difficulty in drawing blood through the 
catheter. Her white blood cell count was 3.7 X 10"L 
with 72% polymorphonuclear leukocytes. Peripheral 
and transcatheter blood specimens were again obtained, 
Table 1 Clinical features of reported cases of bacterenlia caused by Ochvohartrum anthropi 
Ref/year 
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Post-thoracic surgery 
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Acute leukemia 
Acute leukemia 
Acute leukemia 
Acute leukemia 
Acute leukemia 
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Kidney transplant 
Kidney transplant 
Kidney, pancreas transplant 
Heart, kidney transplant 
Kidney transplant 
Acute leukemia 
Granulocytic sarcoma 
Multiple myeloma 
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No 
No 
N o  
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No 
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N 
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N 
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TMP-SMZ/Gen 
TMP-SMZ 
TMP-SMZ/Ami 
C R  
C R  
Gen/CR 
C;en/CR 
Gen/CR 
Gen/CR 
Cip/Imi 
Amox-clav/Ami/DB 
hi/ Gen/CR 
Cef/Net 
Pip/Net/Flu/CR 
Imi 
Ami/CR 
Imi 
Pip/Gen 
None 
None 
None 
None 
None 
Pip/Gen/Flu 
Cip 
Gen/CR 
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Died" 
11 1 ed" 
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Cured 
Relapted 
Cured 
K e l a p d  
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Cured 
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Cured 
Cured 
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CKB = catheter-related bacteremia, Acq = acquisition; TMP-SMZ = triiiiethoprim-sulfamethoxazole; Gen = gentamicin; BMT = bone 
marrow transplant; Ami = amikacin; CR = catheter removal; Cip = ciprofloxacin; Imi  = itnipenem; Amox-cIm = anioxicillin-cldvuldnic 
acid; DB = debridement; Cef = ceftazidime; Net = netilmicin; Pip = piperacillin; Flu = Bucoiiazole. 
Polymicrobial bacteremia: 1 = Co~namunas aridovorms; 2 = C a d I d a  dbirans; 3 = Hurkholdevin r p & .  
a = after caesarean section; b = not related to study. 
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following which gentamicin was added to the treat- 
ment and the catheter removed. 
All blood cultures yielded 0. anthropi, as 
identified by the API 20 NE system. Susceptibility 
testing by a microdilution broth method showed that 
the organism was susceptible to imipenem [minimum 
inhibitory concentration (MIC) = 0.5 mg/L], genta- 
micin (MIC = 0.25 mg/L), ciprofloxacin (MIC < 0.12 
mg/L) and trimethoprim-sulfamethoxazole (MIC 
< 0.12 to 2.5 mg/L), and resistant to ampicillin, 
ceazolin, cefotaxime and ceftazidime. After the suscep- 
tibility test results were available, ceftazidinie was 
stopped and the patient received gentamicin alone for 
7 days. The fever disappeared after 48 h of this latter 
treatment. Catheter tip culture was negative. 
Of 26 cases (including ours) in which this pathogen 
has been recovered from blood cultures [l-101, I 6  
appeared to have catheter-related bacteremia (Table I) ,  
five had bacteremia after receiving rabbit antithymocyte 
globulin [2], one had bacteremia and urinary tract 
infection after cystourethroscopy [5], one (an alcoholic 
woman) had septicemia and necrotizing fasciitis, one 
(with 0. anthropi isolated from the lung; our Case one) 
developed polymicrobial bacteremia 8 days later, and 
two had bacteremia of unknown origin [3,9]. Twenty 
of the 26 patients were women [1-101 and six were 
men [2,6]; 19 were immunosuppressed with malig- 
nancies (n = 13) [1,2,5,6,8-101, solid organ transplants 
(n = 5) [2] and alcoholism (n = 1) [lo]; in four patients, 
the bacteremia was polymicrobial [6,8], and most (21 
out of 24 with available data) of the bactereniic 
infections were nosocomially acquired [I-3,5,6,8,9]. 
Although some patients were immunocompromised, 
the infections appeared to be relatively benign and no 
deaths were associated with 0. anthropi infection. 
The antibiotic susceptibility data for 0. anthropi 
strains isolated from blood cultures are summarized in 
Table 2. The role and efficacy of antimicrobial chemo- 
therapy in these infections are difficult to define 
because of the many different regimens used. In eight 
previously reported cases, patients recovered from 
episodes of 0. anthropi bacteremia without antibiotic 
therapy [2], following treatment with antibiotics against 
which the strains appeared to be resistant in vitro [9] or 
after removal of an infected catheter [6]. In view of the 
previous antibiotic susceptibility data, the most suitable 
drugs appear to be imipenem, the newer fluoro- 
quinolones and the aminoglycosides (amikacin or genta- 
micin) for the treatment of infection by 0. anthropi in 
cases where such treatment is clinically necessary. 
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Table 2 Antimicrobial susceptibility of Ochrobactrurn 
nnthropi isolates from blood cultures 
Antibiotic Strains tested (n)  Sensitive (%) 
Anipicillin 26 0 
Aniox-clav 22 0 
Mezlocillin 18 0 
Cefazolin/cephalothin 18 0 
Cefuroxime 18 0 
Cefotaxime/ceftriaxone 20 3 
Ceftazidinie 20 10 
Aztreonam 20 0 
Iniipenem 25 100 
Gcntaniicin 20 85 
Tobramycin 18 67 
Amikacin 25 85 
Ofloxacin 9 89 
TMP-SMZ 21 76 
Ciprofloxacin 19 95 
Tetracycline 13 69 
Ainox-clav = amoxicdlin-clavulanic acid; TMP-SMZ = 
trimethoprim-sulfamethoxazole. 
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